Home›Oxymetazoline Hydrochloride›Oxymetazoline Hydrochloride + Anti Arrhythmics

Does Oxymetazoline Hydrochloride Interact with Anti Arrhythmics?

CDI records a moderate classification for Oxymetazoline Hydrochloride and Anti Arrhythmics. The stored summary is: Alpha-adrenergic agonists may impact blood pressure; caution advised when used with anti-hypertensive drugs. The mechanism involves alpha-adrenergic agonist effects on blood pressure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity: Moderate
Management: Monitor for effects
Data Source: U.S. FDA via OpenFDA

Recorded Mechanism

Alpha-adrenergic agonist effects on blood pressure

What To Tell Your Doctor or Pharmacist

If you are taking Oxymetazoline Hydrochloride and your doctor is considering prescribing Anti Arrhythmics (or vice versa), make sure to:

Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
Ask whether the benefits of combining these medications outweigh the risks for your specific situation
Ask what symptoms to watch for that would indicate the interaction is causing problems
Ask whether any dosage adjustments are needed
Never stop or change either medication without first consulting your healthcare provider

💊 Oxymetazoline Hydrochloride(Rhofade)+💊 Anti Arrhythmics(Anti Bac)

Severity & Interaction Details

🟡

moderate

Be aware — moderate interaction

Documented interaction with manageable risk. May require dose adjustment or monitoring.

Severity scale

MinorContra

On record

Yes

Drug A class

—

Drug B class

—

Source

NLP:oxymetazoline hydrochloride

What this means in plain English

Alpha-adrenergic agonists may impact blood pressure; caution advised when used with anti-hypertensive drugs.

About Oxymetazoline Hydrochloride and Anti Arrhythmics

Oxymetazoline Hydrochloride is also sold under the brand name Rhofade.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:oxymetazoline hydrochloride

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

FDA

FDA Safety Alert: Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 10about Oxymetazoline Hydrochloride · 2026-05

PubMed

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study.about Oxymetazoline Hydrochloride · 2026-04

PubMed

Safety Analysis of Oxymetazoline Eye Drops for Blepharoptosis Using the FDA Adverse Event Reporting System.about Oxymetazoline Hydrochloride · 2026-04

FDA

FDA Safety Alert: UltraSure Anti-Perspirant & Deodorant, Aluminum Sesquichlorohydrate 15%, 118 mL (4 fl. oz.), DermaRiabout Anti Arrhythmics · 2025-11

Share this result:

WhatsApp Text / SMS Email

Also share on:X Facebook

Add more drugs

Check Oxymetazoline Hydrochloride and Anti Arrhythmics against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.